Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Lymphoma

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    March 2024
  1. KIM DH, Siddiqui S, Jain P, Wang M, et al
    TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
    Hum Pathol. 2024;146:1-7.
    PubMed     Abstract available


    February 2024
  2. XU T, Zhang X, Zhu J, Huang C, et al
    Angioimmunoblastic T-cell lymphoma involving the nasopharynx: An easily misdiagnosed disease with atypical histopathological features.
    Hum Pathol. 2024;145:86-94.
    PubMed     Abstract available


    January 2024
  3. QUESADA AE, Hu S, Li S, Toruner GA, et al
    Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
    Hum Pathol. 2024 Jan 30:S0046-8177(24)00013.
    PubMed     Abstract available


    December 2023
  4. RONEN S, McAfee JL, Curry JL, Nagarajan P, et al
    Phenotypic switch in mycosis fungoides: A tertiary cancer center experience.
    Hum Pathol. 2023;142:27-33.
    PubMed     Abstract available


    November 2023
  5. LE MK, Oishi N, Satou A, Miyaoka M, et al
    Molecular and clinicopathological features of granzyme B-negative extranodal NK/T-cell lymphoma.
    Hum Pathol. 2023;143:10-16.
    PubMed     Abstract available


  6. FADL A, Oishi N, Shi M, Dasari S, et al
    Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
    Hum Pathol. 2023;141:6-14.
    PubMed     Abstract available


    October 2023
  7. SALEH JS, Subtil A, Hristov AC
    Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
    Hum Pathol. 2023 Oct 4:S0046-8177(23)00204-6. doi: 10.1016/j.humpath.2023.
    PubMed     Abstract available


    August 2023
  8. YUAN J, Liu H, Hu S, Miranda RN, et al
    Follicular Lymphoma and Diffuse Large B-cell Lymphoma with BCL2 and IRF4 Rearrangements in Adult Patients.
    Hum Pathol. 2023 Aug 25:S0046-8177(23)00172.
    PubMed     Abstract available


  9. STUEBER T, Jaitly V, Moore EM
    The Clinical Significance of Increased Large Cells in Marginal Zone Lymphoma.
    Hum Pathol. 2023 Aug 24:S0046-8177(23)00169.
    PubMed     Abstract available


    July 2023
  10. MANSOOR A, Akhter A, Kamran H, Minoo P, et al
    "Unraveling the Molecular Landscape: A Comparative Analysis of PI3K and MAPK Signaling Pathways in Plasmablastic Lymphoma and Diffuse Large B-cell Lymphoma with Therapeutic Implications".
    Hum Pathol. 2023 Jul 29:S0046-8177(23)00161.
    PubMed     Abstract available


  11. SUNG HJ, Kim D, Yoon DH, Cho H, et al
    Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma.
    Hum Pathol. 2023 Jul 28:S0046-8177(23)00160.
    PubMed     Abstract available


  12. DIAZ DE LA PINTA FJ, Rodriguez Moreno M, Salgado RN, Carvajal Garcia N, et al
    Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background.
    Hum Pathol. 2023;137:71-78.
    PubMed     Abstract available


    June 2023
  13. SALEH JS, Subtil A, Hristov AC
    Primary Cutaneous T-cell Lymphoma: A Review of the Most Common Entities with Focus on Recent Updates.
    Hum Pathol. 2023 Jun 10:S0046-8177(23)00134.
    PubMed     Abstract available


  14. UCCELLA S, Goteri G, Maiorana A, Donati V, et al
    Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas.
    Hum Pathol. 2023;136:44-55.
    PubMed     Abstract available


    May 2023
  15. MAESHIMA AM, Taniguchi H, Furukawa H, Hattori D, et al
    Diagnostic clues of BCL2-negative, faint, or controversial follicular lymphomas: a study of 103 cases.
    Hum Pathol. 2023;135:84-92.
    PubMed     Abstract available


    April 2023
  16. KIM H, Shin D, Son SM, Cho J, et al
    Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma(☆,☆☆,☆☆☆).
    Hum Pathol. 2023 Apr 11:S0046-8177(23)00086.
    PubMed     Abstract available


    March 2023
  17. SHESTAKOVA A, Shao L, Smith LB, Ryan R, et al
    High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: Clinicopathologic, cytogenetic and molecular characterization of 4 cases.
    Hum Pathol. 2023 Mar 28:S0046-8177(23)00073.
    PubMed     Abstract available


    January 2023
  18. PAIK JH, Koh J, Han B, Kim S, et al
    Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Hum Pathol. 2023;131:47-60.
    PubMed     Abstract available


  19. CHEN J, Yang Y, Luo B, Wen Y, et al
    Further predictive value of lymphovascular invasion explored via supervised deep learning for lymph node metastases in breast cancer.
    Hum Pathol. 2023;131:26-37.
    PubMed     Abstract available


    December 2022
  20. XU J, Li S, Yin CC, Patel KP, et al
    Classic Hodgkin Lymphoma with Marked Granulomatous Reaction: A Clinicopathologic Study of 20 Cases.
    Hum Pathol. 2022 Dec 27:S0046-8177(22)00292.
    PubMed     Abstract available


  21. BERG HE, Peterson JF, Lee HE, McPhail ED, et al
    Large B-cell lymphoma with IRF4 gene rearrangements: differences in clinicopathologic, immunophenotypic and cytogenetic features between pediatric and adult patients.
    Hum Pathol. 2022 Dec 2:S0046-8177(22)00274-X. doi: 10.1016/j.humpath.2022.
    PubMed     Abstract available


    October 2022
  22. QIU L, Nwogbo OV, Medeiros LJ, Thakral B, et al
    Lymphoplasmacytic Lymphoma with IgG or IgA Paraprotein: A Study of 29 Cases including Cases that Can Mimic Plasma Cell Neoplasms.
    Hum Pathol. 2022 Oct 13. pii: S0046-8177(22)00244.
    PubMed     Abstract available


    August 2022
  23. FEI F, Kiruthiga KG, Younes S, Natkunam Y, et al
    EBV-Positive Nodular Lymphocyte Predominant Hodgkin Lymphoma: A Single Institution Experience.
    Hum Pathol. 2022 Aug 17. pii: S0046-8177(22)00209.
    PubMed     Abstract available


    April 2022
  24. RYDER CB, Oduro KA, Moore EM
    Monoclonal B-cell Lymphocytosis in the Bone Marrow: Revisiting the Criteria for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Hum Pathol. 2022 Apr 23. pii: S0046-8177(22)00100.
    PubMed     Abstract available


  25. SIDDIQUI F, Perez Silos V, Karube K, Gukso S, et al
    B-cell lymphoma-2 (BCL2) downregulation is a useful feature -supporting a neoplastic phenotype in mature T-cell lymphomas.
    Hum Pathol. 2022 Apr 19. pii: S0046-8177(22)00081.
    PubMed     Abstract available


  26. RAVINDRAN A, Kurtin PJ, King RL, Yuan J, et al
    Aberrant Expression of Lymphoid Enhancer-Binding Factor 1 (LEF1) in Hodgkin Lymphoma.
    Hum Pathol. 2022 Apr 11. pii: S0046-8177(22)00082.
    PubMed     Abstract available


    March 2022
  27. RIGHI S, Novero D, Godio L, Bertuzzi C, et al
    Myeloid Nuclear Differentiation Antigen (MNDA): an aid in differentiating lymphoplasmayctic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.
    Hum Pathol. 2022 Mar 23. pii: S0046-8177(22)00072.
    PubMed     Abstract available


  28. MAESHIMA AM, Taniguchi H, Hattori D, Sasaki H, et al
    CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: A histopathological study of 118 cases.
    Hum Pathol. 2022 Mar 17. pii: S0046-8177(22)00069.
    PubMed     Abstract available


  29. RANGAN A, Reinig E, McPhail ED, Rech KL, et al
    Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas.
    Hum Pathol. 2022;121:29-35.
    PubMed     Abstract available


    January 2022
  30. HORI Y, Yamamoto H, Kawatoko S, Nozaki Y, et al
    Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: A clinicopathological study of 15 cases.
    Hum Pathol. 2022 Jan 3. pii: S0046-8177(21)00218.
    PubMed     Abstract available


    November 2021
  31. ZHANG Q, Kim DH, Xu Y, Wang W, et al
    Clinicopathological Features of Syncytial Variant Nodular Sclerosis Hodgkin lymphoma.
    Hum Pathol. 2021 Nov 18. pii: S0046-8177(21)00195.
    PubMed     Abstract available


  32. QIU L, Xu J, Tang G, Wang SA, et al
    Mantle Cell Lymphoma with Chronic Lymphocytic Leukemia-Like Features: A Diagnostic Mimic and Pitfall.
    Hum Pathol. 2021 Nov 9. pii: S0046-8177(21)00184.
    PubMed     Abstract available


    October 2021
  33. TASHAKORI M, Kim DH, Kanagal-Shamanna R, Vega F, et al
    Mantle Cell Lymphoma Involving Tonsils: A Clinicopathologic Study of 83 Cases.
    Hum Pathol. 2021 Oct 13. pii: S0046-8177(21)00179.
    PubMed     Abstract available


    August 2021
  34. KIISKILA J, Uotila P, Haapasaari KM, Kauppila S, et al
    Incidence and clinicopathological features of Follicular T-cell lymphoma in Finland; a population-based immunohistochemical study.
    Hum Pathol. 2021 Aug 5. pii: S0046-8177(21)00139.
    PubMed     Abstract available


  35. IWAFUCHI H, Nakazawa A, Sekimizu M, Mori T, et al
    Clinicopathological features and prognostic significance of PD-L1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.
    Hum Pathol. 2021 Aug 4. pii: S0046-8177(21)00132.
    PubMed     Abstract available


    May 2021
  36. WANG W, Zhang Q, Medeiros LJ
    Syncytial Variant of Nodular Sclerosis Hodgkin Lymphoma: An Under-emphasized Variant.
    Hum Pathol. 2021 May 28. pii: S0046-8177(21)00093.
    PubMed     Abstract available


  37. CHAUDHARY S, Brown N, Song JY, Yang L, et al
    Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
    Hum Pathol. 2021 May 5. pii: S0046-8177(21)00072.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.